PortViewPortView
Churchill Capital Corp. Xiii logo

Churchill Capital Corp. Xiii (XIII) Stock Analysis

NASDAQFinancial ServicesFinancial - Conglomerates

$10.27+0.20%
1-year price historyRange $10.05 – $10.72
52-week range$10.27
$10.01$11.25

Track XIII in your portfolio for free · Portfolio tracker

What Churchill Capital Corp. Xiii does

Churchill Capital Corp. XIII is a blank check company. The company was founded by Michael Klein on January 13, 2026 and is headquartered in New York, NY.

Key metrics

Market cap
$428.77M
Beta
0.00
50-day avg
$10.24
200-day avg
$10.24
52-week high
$11.25
52-week low
$10.01
CEO
Michael Stuart Klein

ETFs linked to XIII

Broad-market and Financial Services sector ETFs an investor holding Churchill Capital Corp. Xiii is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how XIII fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze XIII in PortView →

Frequently asked questions

What is the ticker symbol for Churchill Capital Corp. Xiii?
Churchill Capital Corp. Xiii trades under the ticker XIII on NASDAQ.
Which exchange is XIII listed on?
XIII is listed on NASDAQ.
What sector does Churchill Capital Corp. Xiii operate in?
Churchill Capital Corp. Xiii is classified in the Financial Services sector (Financial - Conglomerates industry).
How can PortView help analyze XIII in a portfolio?
PortView shows XIII's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.